Medical services provider Zhongchao Inc. (ZCMD, Financial) saw its stock rise by over 5%, reaching $2.52. This increase highlights investor interest in the company, despite mixed performance in the broader sector of Chinese pharmaceutical stocks listed in the U.S.
In a broader context, other Chinese pharmaceutical stocks experienced varied movements. BeiGene Ltd. (BGNE) and Zai Lab Limited (ZLAB) saw slight gains, while Hutchison China MediTech Limited (HCM) experienced a decline of over 5%.